Antonio Oliver Selected Research

zidebactam

1/2020	Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa.
1/2019	In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae.
1/2017	WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Oliver Research Topics

Disease

79	Infections 01/2024 - 08/2006
17	Cystic Fibrosis (Mucoviscidosis) 05/2024 - 02/2009
17	Sepsis (Septicemia) 03/2022 - 01/2010
16	Pseudomonas Infections 01/2023 - 05/2006
14	Persistent Infection 03/2024 - 11/2004
10	Respiratory Tract Infections (Respiratory Tract Infection) 10/2023 - 06/2008
6	Bacteremia 08/2022 - 01/2010
6	Cross Infection (Nosocomial Infection) 01/2021 - 05/2010
5	Communicable Diseases (Infectious Diseases) 12/2023 - 03/2009
5	COVID-19 01/2023 - 01/2021
4	Chronic Obstructive Pulmonary Disease (COPD) 07/2022 - 04/2012
3	Healthcare-Associated Pneumonia 04/2024 - 10/2008
3	Inflammation (Inflammations) 01/2023 - 10/2019
3	Urinary Tract Infections (Urinary Tract Infection) 11/2022 - 09/2008
3	Pneumonia (Pneumonitis) 11/2022 - 01/2015
3	Wounds and Injuries (Trauma) 10/2022 - 03/2010
3	Body Weight (Weight, Body) 11/2019 - 04/2014
2	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2015
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 11/2018
2	Ventilator-Associated Pneumonia 01/2021 - 10/2019
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 01/2016
1	Central Nervous System Infections (Central Nervous System Infection) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Necrosis 01/2023
1	Burns 10/2022
1	Candidiasis (Moniliasis) 08/2022
1	Intraabdominal Infections 03/2022
1	Bacterial Pneumonia 03/2022

Drug/Important Bio-Agent (IBA)

31	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 11/2004
14	LactamsIBA 01/2020 - 12/2011
13	Meropenem (Merrem)FDA LinkGeneric 11/2022 - 04/2012
12	Carbapenems (Carbapenem Antibiotics)IBA 06/2023 - 03/2012
11	tazobactam drug combination ceftolozaneIBA 01/2023 - 01/2018
10	ceftazidime drug combination avibactamIBA 12/2023 - 10/2016
8	Tobramycin (Nebcin)FDA LinkGeneric 03/2024 - 03/2015
8	Ceftazidime (Fortum)FDA LinkGeneric 01/2022 - 09/2012
7	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023 - 05/2006
6	Imipenem FDA Link 01/2023 - 04/2012
5	Peptidoglycan (Murein)IBA 03/2024 - 12/2018
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2013
5	Proteins (Proteins, Gene)FDA Link 03/2020 - 02/2008
5	Colistin (Coly-Mycin)FDA Link 01/2020 - 03/2015
5	beta-Lactamases (beta-Lactamase)IBA 05/2010 - 08/2006
4	CefiderocolIBA 05/2024 - 03/2022
4	Aztreonam FDA LinkGeneric 03/2024 - 03/2015
4	carbapenemaseIBA 11/2023 - 06/2008
4	Fosfomycin FDA Link 01/2018 - 09/2008
3	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2023 - 03/2015
3	CytokinesIBA 07/2022 - 03/2010
3	zidebactamIBA 01/2020 - 01/2017
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 05/2024 - 02/2009
2	EnzymesIBA 01/2024 - 05/2010
2	PyocyanineIBA 10/2023 - 01/2020
2	relebactamIBA 01/2023 - 10/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 10/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2021
2	Pancreatic Elastase (Elastase)IBA 01/2021 - 02/2017
2	CephalosporinaseIBA 01/2021 - 05/2006
2	cefepime-zidebactamIBA 01/2021 - 01/2020
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 04/2009
2	Anti-Infective Agents (Microbicides)IBA 04/2020 - 09/2008
2	Cefepime (Maxipime)FDA LinkGeneric 01/2020 - 01/2017
2	WCK 5153IBA 01/2019 - 01/2017
2	AminoglycosidesIBA 01/2018 - 04/2015
2	Amoxicillin (Wymox)FDA LinkGeneric 07/2013 - 09/2008
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 07/2013 - 09/2008
2	ceftolozaneIBA 09/2012 - 07/2010
2	Penicillins (Penicillin)FDA Link 09/2008 - 05/2006
1	Inosine Monophosphate (IMP)IBA 11/2023
1	AntigensIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	CalciumIBA 01/2023
1	gremubamabIBA 11/2022
1	Monoclonal AntibodiesIBA 11/2022
1	Doripenem FDA Link 09/2022
1	Fluconazole (Zonal)FDA LinkGeneric 08/2022
1	Toll-Like Receptor 2IBA 07/2022
1	Transcription Factors (Transcription Factor)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	SiderophoresIBA 03/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	alkaline proteaseIBA 01/2021
1	avibactamIBA 01/2021
1	AntibodiesIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	SolutionsIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021

Therapy/Procedure

30	Therapeutics 12/2023 - 08/2008
3	Mechanical Ventilators (Ventilator) 03/2022 - 11/2018
2	Length of Stay 01/2018 - 04/2014
1	Critical Care (Surgical Intensive Care) 01/2023
1	Duration of Therapy 08/2022
1	Lasers (Laser) 06/2021
1	Aftercare (After-Treatment) 01/2021